- Home
- KRNY vs YDES Comparison
KRNY vs YDES Comparison
Compare KRNY & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | KRNY | YDES |
|---|---|---|
| Founded | 1884 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Savings Institutions | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 511.9M | 543.0M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | KRNY | YDES |
|---|---|---|
| Price | $8.06 | $5.35 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 257.6K | 22.4K |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | ★ 5.33% | N/A |
| EPS Growth | ★ 130.22 | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $2,580,000.00 | N/A |
| Revenue This Year | $3.89 | N/A |
| Revenue Next Year | $17.52 | N/A |
| P/E Ratio | $27.50 | ★ N/A |
| Revenue Growth | ★ 36.00 | N/A |
| 52 Week Low | $5.76 | $5.00 |
| 52 Week High | $8.50 | $25.00 |
Technical Indicators
Market Signals| Indicator | KRNY | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 55.49 | 35.23 |
| Support Level | $7.77 | N/A |
| Resistance Level | $8.27 | $13.19 |
| Average True Range (ATR) | 0.22 | 0.51 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 74.52 | 13.13 |
Price Performance
Historical ComparisonAbout KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.